Unicycive Therapeutics In...

0.54
-0.02 (-4.34%)
At close: Feb 28, 2025, 3:59 PM
0.55
2.67%
After-hours: Feb 28, 2025, 04:00 PM EST

Unicycive Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 9.7M 455K 16.58M n/a 15K 25K
Short-Term Investments n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a -174K -333K 200K n/a n/a
Receivables n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Other Current Assets 3.7M 2.19M 1.83M 204K 4K 4K
Total Current Assets 13.4M 2.64M 18.41M 204K 19K 29K
Property-Plant & Equipment 792K 174K 333K n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 792K 174K 333K 200K n/a n/a
Total Assets 14.19M 2.82M 18.74M 204K 19K 29K
Account Payables 821K 846K 713K 184K 322K 60K
Deferred Revenue -18K n/a n/a n/a n/a 1.00
Short-Term Debt 345K 310K 302K 2.51M 460K 1.05M
Other Current Liabilities 16.37M 2.13M 1.09M 177K 121K 128K
Total Current Liabilities 17.53M 3.28M 2.1M 2.88M 903K 1.24M
Long-Term Debt 466K n/a 155K n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 466K 1.05K 155K n/a n/a n/a
Total Liabilities 18M 3.28M 2.26M 2.88M 903K 1.24M
Total Debt 811K 155K 306K 2.51M 460K 1.05M
Common Stock 35K 15K 15K 9K 8K 34K
Retained Earnings -64.54M -34M -15.94M -5.92M -3.66M -1.49M
Comprehensive Income n/a n/a n/a n/a n/a 0.00
Shareholders Equity -3.81M -466K 16.48M -2.67M -884K -1.21M
Total Investments n/a n/a n/a n/a n/a n/a